June 26, 2018
Video
Folate receptor alpha was a promising biomarker when it came to treatment with mirvetuximab soravtansine.
I Never Expected to Be the Caregiver with Cancer
Spring Into the Season With New Recipes
How I Wish You Were Still Here to See it All
Kathy Ireland Joins the National Pediatric Cancer Foundation’s ‘Team 43’ to Raise Funds and Awareness